December 2015

The German Cancer Research Center (DKFZ) in Heidelberg (Europes leading oncology center) decided to for the Maintrac-System, after several years of evaluation and comparission studies with other CTC-methods."Maintrac is by far the most advanced system in the market and suitable for clinical use". At the moment a laboratory facility is under construction. The first prototype for the first external, quantitative measurement of circulating tumor cells (CTCs) was delivered. Several clinical trials are in planning.